Clinical Trials Logo

Clinical Trial Summary

The goal of this observational study is to learn about the presence of extracutaneous manifestations in patients with congenital ichthyosis. The main question it aims to answer is: - Do patients with congenital ichthyosis experience extracutaneous manifestations? Participants will fill in questionnaires in which the investigators will explore whether patients experience extracutaneous manifestations, and if so what these manifestations entail. Examples of such questions are whether patients experience (joint) pain or whether they experience hindrance due to their complaints.


Clinical Trial Description

There is only limited knowledge about extracutaneous manifestations in patients with congenital ichthyosis. With this study, the investigators aim to identify extracutaneous manifestations with questionaires based on patient reported outcomes. Secondary research questions include: - What is the prevalence of joint complaints in patients with congenital ichthyosis - What is the influence of ichthyosis on the quality of life patients experience Furthermore, the investigators aim to discover knowledge gaps in current patient management and possible areas of improvement in patient care towards healthcare professionals. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06123091
Study type Observational
Source Maastricht University Medical Center
Contact Vanya Rossel, MD
Phone +31(0)43-3877295
Email vanya.rossel@mumc.nl
Status Recruiting
Phase
Start date September 1, 2023
Completion date December 1, 2024

See also
  Status Clinical Trial Phase
Completed NCT05610306 - Quality of Life in Middle-aged and Older Patients With Congenital Ichthyosis
Completed NCT02864082 - A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis Phase 2
Recruiting NCT04996485 - Scientific Substantiation and Assessment of the Effectiveness of Pathogenetic Methods of Therapy for Congenital Ichthyosis in Children Phase 4
Completed NCT04154293 - A Vehicle Controlled Study to Evaluate Safety and Efficacy of Topical TMB-001 for Treatment of Congenital Ichthyosis Phase 2